Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats

Status
Not open for further replies.
P

Biglemon said:
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

www.nytimes.com
Paywall.
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,620
Messages
55,146
Members
1
Latest member
Admin
Back
Top